Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells

被引:87
作者
Hughes, AK [1 ]
Stricklett, PK [1 ]
Kohan, DE [1 ]
机构
[1] Univ Utah, Sch Med, Salt Lake City, UT USA
关键词
proximal tubule; cytokines; cytotoxicity; interleukin-1; butyrate; hemolytic uremic syndrome; infection; diarrhea in children;
D O I
10.1046/j.1523-1755.1998.00015.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Cytolytic Shiga toxins (Stx) are believed to be largely responsible for renal damage in post-diarrheal hemolytic-uremic syndrome (D+HUS). Despite the general belief that endothelial cells are the primary target of Stx, there is evidence that proximal tubules may be a site of toxin action. We hypothesized that cultured proximal tubular cells are sensitive to the cytotoxic effects of Stx. Methods. Cultured human proximal tubular cells were exposed to Stx-1 in the presence and absence of a variety of inflammatory factors likely to be elevated in the kidney or serum of patients with D+HUS. Cell survival, protein synthesis, total cell levels and synthesis of Stx receptors (GB3), and Stx binding were measured. Results. Proximal tubules were extremely sensitive to the cytotoxic effect of Stx-1 with an LD50 at least equal to, if not less than, that seen with Vero cells. Interleukin-1 (IL-1), lipopolysaccharide (LPS), and butyrate (but not tumor necrosis factor or interleukin-6) up-regulated proximal tubule sensitivity to Stx-1. IL-1 increased Stx-1 binding, but did not alter total cell levels or synthesis of GB3, the glycosphingolipid receptor for Stx-1. In contrast, LPS and butyrate, despite increasing Stx-1 sensitivity, had no effect on Stx-1 binding. Conclusions. These studies indicate that proximal tubules are exquisitely sensitive to Stx-1 cytotoxicity and that inflammatory factors can increase toxin responsiveness through a variety of mechanisms. It is suggested that proximal tubules may be an important early target of Stx-1 action in D+HUS.
引用
收藏
页码:426 / 437
页数:12
相关论文
共 32 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   HIGH-INCIDENCE OF SERUM ANTIBODIES TO ESCHERICHIA-COLI O157 LIPOPOLYSACCHARIDE IN CHILDREN WITH HEMOLYTIC-UREMIC SYNDROME [J].
BITZAN, M ;
MOEBIUS, E ;
LUDWIG, K ;
MULLERWIEFEL, DE ;
HEESEMANN, J ;
KARCH, H .
JOURNAL OF PEDIATRICS, 1991, 119 (03) :380-385
[3]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
COLDHAM NG, 1995, DRUG METAB DISPOS, V23, P501
[6]  
Garz C, 1997, J AM SOC NEPHROL, V8, pA2801
[7]   A REPORTER TRANSGENE INDICATES RENAL-SPECIFIC INDUCTION OF TUMOR-NECROSIS-FACTOR (TNF) BY SHIGA-LIKE TOXIN - POSSIBLE INVOLVEMENT OF TNF IN HEMOLYTIC-UREMIC SYNDROME [J].
HAREL, Y ;
SILVA, M ;
GIROIR, B ;
WEINBERG, A ;
CLEARY, TB ;
BEUTLER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2110-2116
[8]   PATHOGENESIS OF SHIGELLA DIARRHEA .17. A MAMMALIAN-CELL MEMBRANE GLYCOLIPID, GB3, IS REQUIRED BUT NOT SUFFICIENT TO CONFER SENSITIVITY TO SHIGA TOXIN [J].
JACEWICZ, MS ;
MOBASSALEH, M ;
GROSS, SK ;
BALASUBRAMANIAN, KA ;
DANIEL, PF ;
RAGHAVAN, S ;
MCCLUER, RH ;
KEUSCH, GT .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03) :538-546
[9]  
JACEWICZ MS, 1994, 2 INT S WORKSH VER S, P64
[10]   SHIGA TOXIN-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME - INTERLEUKIN-1-BETA ENHANCEMENT OF SHIGA TOXIN CYTOTOXICITY TOWARD HUMAN VASCULAR ENDOTHELIAL-CELLS IN-VITRO [J].
KAYE, SA ;
LOUISE, CB ;
BOYD, B ;
LINGWOOD, CA ;
OBRIG, TG .
INFECTION AND IMMUNITY, 1993, 61 (09) :3886-3891